Literature DB >> 16087406

Axons mediate the distribution of arylsulfatase A within the mouse hippocampus upon gene delivery.

Tonia Luca1, Maria I Givogri, Laura Perani, Francesca Galbiati, Antonia Follenzi, Luigi Naldini, Ernesto R Bongarzone.   

Abstract

Axonal transport of the lysosomal enzyme arylsulfatase A (ARSA) may be an additional mechanism of enzyme distribution after in vivo brain gene transfer in an animal model of metachromatic leukodystrophy (MLD). Direct molecular demonstration of the movement of this lysosomal enzyme within axonal networks was missing. We generated lentiviral vectors carrying the ARSA cDNA tagged with hemagglutinin or the green fluorescent protein and examined the subcellular localization and anatomical distribution of the tagged enzymes within the MLD hippocampus after in vivo lentiviral gene transfer. The use of tagged ARSA allowed direct real-time observation and tracking of axon-dendritic transport of the enzyme after lentiviral gene therapy. Tagged ARSA was expressed in transduced pyramidal, granule, and hilar neurons within the lentiviral-injected side and was robustly contained in vesicles within ipsilateral axon-dendritic processes as well as in vesicles associated with contralateral axons and commissural axons of the ventral hippocampal commissure. Axonal transport of tagged ARSA led to the correction of hippocampal defects in long-term treated MLD mice, which was accompanied by enzyme uptake in nontransduced contralateral neurons, enzyme accumulation within the lysosomal compartment, and clearance of sulfatide storage deposits in this region of the MLD brain. These results contribute to the understanding of the mechanisms of distribution of lysosomal enzymes within the mammalian brain after direct gene therapy, demonstrating the use of neural processes for enzyme transport.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087406     DOI: 10.1016/j.ymthe.2005.06.438

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  19 in total

1.  Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.

Authors:  Françoise Piguet; Dolan Sondhi; Monique Piraud; Françoise Fouquet; Neil R Hackett; Ornella Ahouansou; Marie-Thérèse Vanier; Ivan Bieche; Patrick Aubourg; Ronald G Crystal; Nathalie Cartier; Caroline Sevin
Journal:  Hum Gene Ther       Date:  2012-07-23       Impact factor: 5.695

Review 2.  Gene therapy for the neurological manifestations in lysosomal storage disorders.

Authors:  Seng H Cheng
Journal:  J Lipid Res       Date:  2014-03-29       Impact factor: 5.922

Review 3.  Gene therapy for metachromatic leukodystrophy.

Authors:  Jonathan B Rosenberg; Stephen M Kaminsky; Patrick Aubourg; Ronald G Crystal; Dolan Sondhi
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

4.  Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.

Authors:  Jonas Doerr; Annika Böckenhoff; Benjamin Ewald; Julia Ladewig; Matthias Eckhardt; Volkmar Gieselmann; Ulrich Matzner; Oliver Brüstle; Philipp Koch
Journal:  Mol Ther       Date:  2015-06-10       Impact factor: 11.454

5.  Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain.

Authors:  Diane Golebiowski; Imramsjah M J van der Bom; Churl-Su Kwon; Andrew D Miller; Keiko Petrosky; Allison M Bradbury; Stacy Maitland; Anna Luisa Kühn; Nina Bishop; Elizabeth Curran; Nilsa Silva; Dwijit GuhaSarkar; Susan V Westmoreland; Douglas R Martin; Matthew J Gounis; Wael F Asaad; Miguel Sena-Esteves
Journal:  Hum Gene Ther       Date:  2017-01-26       Impact factor: 5.695

6.  Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis.

Authors:  Marco A Passini; James C Dodge; Jie Bu; Wendy Yang; Qi Zhao; Dolan Sondhi; Neil R Hackett; Stephen M Kaminsky; Qinwen Mao; Lamya S Shihabuddin; Seng H Cheng; David E Sleat; Gregory R Stewart; Beverly L Davidson; Peter Lobel; Ronald G Crystal
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

7.  Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells.

Authors:  Katarzyna C Pituch; Ana L Moyano; Aurora Lopez-Rosas; Felecia M Marottoli; Guannan Li; Chenqi Hu; Richard van Breemen; Jan E Månsson; Maria I Givogri
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

8.  AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival.

Authors:  Rena C Baek; Marike L D Broekman; Stanley G Leroy; Laryssa A Tierney; Michael A Sandberg; Alessandra d'Azzo; Thomas N Seyfried; Miguel Sena-Esteves
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

9.  Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters.

Authors:  T Husain; M A Passini; M K Parente; N W Fraser; J H Wolfe
Journal:  Gene Ther       Date:  2009-05-21       Impact factor: 5.250

10.  Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.

Authors:  Alessandra Biffi; Alessia Capotondo; Stefania Fasano; Ubaldo del Carro; Sergio Marchesini; Hisaya Azuma; Maria Chiara Malaguti; Stefano Amadio; Riccardo Brambilla; Markus Grompe; Claudio Bordignon; Angelo Quattrini; Luigi Naldini
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.